In accordance with the Food and Drug Safety Administration's issuance of a reexamination result notice and change order for approval [Cilostazol single agent (oral)] (Drug Management Department-No. 9145, effective date 2008.08.13), the precautions for use of Rosazol Tablet and Rosazol Tablet 100 mg have been changed.
 


For further details, please refer to the ‘Product Introduction’ section and attached documents.